These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20578984)

  • 1. Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options.
    Gandhirajan RK; Poll-Wolbeck SJ; Gehrke I; Kreuzer KA
    Curr Cancer Drug Targets; 2010 Nov; 10(7):716-27. PubMed ID: 20578984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
    Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
    Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
    PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
    Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.
    Gutierrez A; Tschumper RC; Wu X; Shanafelt TD; Eckel-Passow J; Huddleston PM; Slager SL; Kay NE; Jelinek DF
    Blood; 2010 Oct; 116(16):2975-83. PubMed ID: 20595513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
    Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1.
    Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
    Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma.
    Howe D; Bromidge T
    Leuk Res; 2006 Jan; 30(1):29-32. PubMed ID: 16054689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression.
    Gutierrez A; Arendt BK; Tschumper RC; Kay NE; Zent CS; Jelinek DF
    PLoS One; 2011; 6(10):e26056. PubMed ID: 21998751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
    Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
    Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 controls the recruitment of Wnt regulators to target genes in vivo.
    Wang S; Jones KA
    Curr Biol; 2006 Nov; 16(22):2239-44. PubMed ID: 17113388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options.
    Gehrke I; Gandhirajan RK; Kreuzer KA
    Eur J Cancer; 2009 Nov; 45(16):2759-67. PubMed ID: 19729298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anti-Wnt/β-catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system.
    Chuang KA; Lieu CH; Tsai WJ; Wu MH; Chen YC; Liao JF; Wang CC; Kuo YC
    Braz J Med Biol Res; 2010 Oct; 43(10):931-41. PubMed ID: 20835687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-catenin relieves I-mfa-mediated suppression of LEF-1 in mammalian cells.
    Pan W; Jia Y; Huang T; Wang J; Tao D; Gan X; Li L
    J Cell Sci; 2006 Dec; 119(Pt 23):4850-6. PubMed ID: 17090604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
    Gebeshuber CA; Sladecek S; Grunert S
    Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
    Marchetti B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for non-functional Dickkopf-1 (DKK-1) signaling in chronic lymphocytic leukemia (CLL).
    Filipovich A; Gandhirajan RK; Gehrke I; Poll-Wolbeck SJ; Kreuzer KA
    Eur J Haematol; 2010 Oct; 85(4):309-13. PubMed ID: 20618428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
    Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
    BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells.
    Morgan RG; Ridsdale J; Payne M; Heesom KJ; Wilson MC; Davidson A; Greenhough A; Davies S; Williams AC; Blair A; Waterman ML; Tonks A; Darley RL
    Haematologica; 2019 Jul; 104(7):1365-1377. PubMed ID: 30630973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.